The Manitoba human papillomavirus vaccine surveillance and evaluation system.
Health Rep
; 21(2): 37-42, 2010 Jun.
Article
em En
| MEDLINE
| ID: mdl-20632523
ABSTRACT
BACKGROUND:
With the recent introduction of a human papillomavirus (HPV) vaccine in Canada, it is important to establish surveillance and evaluation programs that not only track the uptake of the vaccine, but also assess its safety and its impact on distribution of HPV type, cervical cancer screening programs, the incidence of anogenital warts, precancerous lesions and various cancers, and sexual behaviour. DATA SOURCES ANDMETHODS:
Administrative databases, registries and questionnaire information are being linked to identify people receiving the HPV vaccine and to develop an evaluation system.INTERPRETATION:
The availability of extensive linkable databases in Manitoba allows for the development of a comprehensive HPV vaccine surveillance and evaluation system that can address many of the questions related to the HPV vaccine. Aspects of the Manitoba surveillance and evaluation system could be implemented in other provinces that have similar databases.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Infecções por Papillomavirus
/
Alphapapillomavirus
/
Vacinas contra Papillomavirus
Tipo de estudo:
Screening_studies
Limite:
Adolescent
/
Adult
/
Child
/
Female
/
Humans
País como assunto:
America do norte
Idioma:
En
Ano de publicação:
2010
Tipo de documento:
Article